Pediatric solid organ and hematopoietic stem cell transplantation

1. Pediatric solid organ and hematopoietic stem cell transplantation raises the risk of post-transplant lymphoproliferative disease in humans (SIR > 200).

   “standardized incidence ratios for post-transplant lymphoproliferative disease exceeding 200 in some cohorts”

   Reviewin pediatric transplant recipients

   Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm

   World journal of transplantation·12 Jun 2026

More on Post-transplant lymphoproliferative disease

1. Pediatric solid organ and hematopoietic stem cell transplantation raises the risk of cancer in humans (4- to 20-fold).

   “pediatric recipients demonstrate 4- to 20-fold elevated cancer incidence”

   Reviewin pediatric transplant recipients

   Immunosenescence and cancer predisposition in pediatric transplant recipients: An emerging paradigm

   World journal of transplantation·12 Jun 2026

More on Cancer